HFCP X (Parallel-A), L.P.'s Form 4 filing
Medline Inc. (MDLN) · filed Mar 12, 2026
- Accession no.
- 0001193125-26-104678
- Filed
- Mar 12, 2026, 8:01 PM ET
- Trade date
- Mar 10, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions. Open-market sales total $1.06B. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| HFCP X (Parallel-A), L.P.CIK 0001841189 | 10% Owner |
| Hellman & Friedman Capital Partners X (Parallel), L.P.CIK 0001841430 | 10% Owner |
| Hellman & Friedman Capital Partners X, L.P.CIK 0001841434 | 10% Owner |
| Hellman & Friedman Investors X, L.P.CIK 0001868392 | 10% Owner |
| Mend Partners II, L.P.CIK 0001877047 | 10% Owner |
| H&F Corporate Investors X, Ltd.CIK 0001901930 | 10% Owner |
| Mend Investment Holdings I, L.P.CIK 0002074968 | 10% Owner |
| Mend Partners GP, LLCCIK 0002074972 | 10% Owner |
| Mend Investment Holdings GP, LLCCIK 0002074980 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Class A Common Stock | SSaleDisposed | −14,639,754 | $40.51F1 | −$593,027,155.03 | 558,307 | Indirect | |
| Mar 10, 2026 | Class A Common Stock | SSaleDisposed | −629,933 | $40.51F1 | −$25,517,325.96 | 4,176,227 | Indirect | |
| Mar 10, 2026 | Class A Common Stock | SSaleDisposed | −9,801,455 | $40.51F1,F4 | −$397,037,339.14 | 75,931,567 | Indirect | |
| Mar 10, 2026 | Class A Common Stock | SSaleDisposed | −1,060,095 | $40.51F1,F4 | −$42,942,328.26 | 7,895,482 | Indirect | |
| Mar 10, 2026 | Class A Common Stock | JOtherDisposed | −538,997 | –F5 | – | 19,310 | Indirect | |
| Mar 10, 2026 | Class A Common Stock | JOtherDisposed | −1,435,395 | –F5 | – | 74,496,172 | Indirect | |
| Mar 10, 2026 | Class A Common Stock | JOtherDisposed | −113,694 | –F5 | – | 7,781,788 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This amount represents the $41.00 secondary public offering price per share of Class A common stock ("Class A Common Stock") of Medline Inc. (the "Issuer"), less the underwriting discount of $0.492 per share sold by the Reporting Persons in connection with an underwritten public offering.
Referenced by the price of 4 transactions in Table I.
- F4
On March 10, 2026, Hellman & Friedman Capital Partners X (Parallel), L.P. and HFCP X (Parallel - A), L.P. contributed shares of Class A common stock to certain of their respective wholly owned subsidiaries, which subsidiaries immediately sold such shares in the underwritten public offering referred to above.
Referenced by the price of 2 transactions in Table I.
- F5
On March 10, 2026, in connection with the sales reported above, each of Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), L.P., and Mend Investment Holdings I, L.P. initiated distributions of shares of Class A Common Stock to their respective ultimate partners and shareholders as in-kind distributions in respect of such persons' interests in the distributing entities. The receipt of shares of Class A Common Stock by each of the Reporting Persons in connection with such distributions was exempt from reporting pursuant to Rule 16a-13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").
Referenced by the price of 3 transactions in Table I.
Remarks
The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act. This filing shall not be deemed an admission that for purposes of Section 16 of the Exchange Act, or otherwise, that the Reporting Persons are subject to Section 16 of the Exchange Act or that the Reporting Persons are the beneficial owners of any equity securities in excess of their respective pecuniary interests, and each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.